A Comparison Between Dually Diagnosed Inpatients with and without Axis II Comorbidity and the Relationship to Treatment Outcome

References

• Verheul R. Co-morbidity of personality disorders in individuals with substance use disorders. Eur Psychiatry 2001; 16(5)274–282
   PubMed Web of Science ®Google Scholar
• Brooner RK, King VL, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opiod abusers. Arch Gen Psychiatry 1997; 54: 71–80
   PubMed Web of Science ®Google Scholar
• Driessen M, Veltrup C, Wetterling T, John U, Dilling H. Axis I Axis II comorbidity in alcohol dependence and the two types of alcoholism. Alcohol Clin Exp Res 1998; 22: 77–86
   PubMed Web of Science ®Google Scholar
• Kokkevi A, Stefanis N, Anastasopoulou E, Kostogianni C. Personality disorders in drug abusers: prevalence and their association with Axis I disorders as predictors of treatment retention. Addict Behav 1998; 23: 841–853
   PubMed Web of Science ®Google Scholar
• Morgenstern J, Langenbucher J, Labouvie E, Miller KJ. The comorbidity of alcoholism and personality disorders in a clinical population: prevalence rates and relation to alcohol typology variables. J Abnorm Psychol 1997; 106: 74–84
   PubMed Web of Science ®Google Scholar
• Rounsaville BJ, Kranzler HR, Ball SA, Tennen H, Poling J, Triffleman E. Personality disorders in substance abusers: relation to substance use. J Nerv Ment Dis 1998; 186: 87–95
   PubMed Web of Science ®Google Scholar
• Verheul R, Hartgers C, van den Brink W, Koeter MWJ. The effect of sampling, diagnostic criteria and assessment procedures on the observed prevalence of personality disorders in alcoholics. J Stud Alcohol 1998; 59: 227–236
   PubMedGoogle Scholar
• Verheul R, van den Brink W, Hartgers C. Prevalence of personality disorders among alcoholics and drug addicts: an overview. Eur Addict Res 1995; 1: 166–177
   Google Scholar
• Nace EP, Davis CW, Gaspari JP. Axis II comorbidity in substance abusers. Am J Psychiatry 1991; 148: 118–120
   PubMed Web of Science ®Google Scholar
• Rutherford MJ, Cacciola JS, Alterman AI. Relationships of personality disorders with problem severity in methadone patients. Drug Alcohol Depend 1994; 35: 69–76
   PubMed Web of Science ®Google Scholar
• Kosten TA, Kosten TR, Rounsaville BJ. Personality disorders in opiate addicts show prognostic specificity. J Subst Abuse Treat 1989; 6: 163–168
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Rutherford MJ, Alterman AI, McKay JR, Snider EC. Personality disorders and treatment outcome in methadone maintenance patients. J Nerv Ment Dis 1996; 184: 234–239
   PubMed Web of Science ®Google Scholar
• Nace EP, Davis CW. Treatment outcome in substance abusing patients with a personality disorder. Am J Addict 1993; 2: 26–33
   Google Scholar
• Nace EP, Saxon JJ, Jr, Shore N. Borderline personality disorder and alcoholism treatment: a one-year follow-up study. J Stud Alcohol 1986; 47: 196–200
   PubMed Web of Science ®Google Scholar
• Marlowe DB, Kirby KC, Festinger DS, Husband SD, Platt JJ. Impact of comorbid personality disorders and personality disorder symptoms on outcomes of behavioral treatment for cocaine dependence. J Nerv Ment Dis 1997; 185: 483–490
   PubMed Web of Science ®Google Scholar
• McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch Gen Psychiatry 1983; 40: 620–625
   PubMed Web of Science ®Google Scholar
• Woody GE, McLellan AT, Luborsky L, O'Brien CP, Blaine J, Fox S, Herman I, Beck AT. Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the veterans administration-penn study. Am J Psychiatry 1984; 141: 1172–1177
   PubMed Web of Science ®Google Scholar
• Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts: a 2.5 year follow-up study. Arch Gen Psychiatry 1986; 43: 739–745
   PubMed Web of Science ®Google Scholar
• Reich JH, Green AI. Effect of personality disorders on outcome of treatment. J Nerv Ment Dis 1991; 179: 74–82
   PubMed Web of Science ®Google Scholar
• Pettinati HM, Pierce JD, Jr, Belden PP, Meyers K. The relationship of Axis II personality disorders to other known predictors of addiction treatment outcome. Am J Addict 1999; 8: 136–147
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, Mulvaney FD. The relationship of psychiatric comorbidity to problem severity and treatment outcomes in methadone maintained patients. Drug Alcohol Depend 2001; 61(3)271–280
   PubMed Web of Science ®Google Scholar
• Galanter M, Egelko S, De Leon G, Rohrs C, Franco H. Crack/cocaine abusers in the General Hospital: assessment and initiation of care. Am J Psychiatry 1992; 149: 810–815
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID-I) (User's Guide and Interview) Research Version. Biometric Research Department, New York Psychiatric Institute, New York, NY 1992
   Google Scholar
• First MB, Spitzer RL, Willams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R (SCID), II. Biometric Research Department, New York Psychiatric Institute, New York, NY 1995
   Google Scholar
• Guy W. ECDEU Assessment Manual for Psychopharmacology—Revised (DHEW Publ N. ADM 76-338). U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD 1967; 218–222
   Google Scholar
• Diagnostic and Statistical Manual of Mental Disorders. 4th ed., American Psychiatric Association, Washington, DC 1994; 46–47
   Google Scholar
• Derogatis LR. Brief Symptom Inventory (BSI): Administration, Scoring, and Procedures Manual. 3rd ed., National Computer Systems, Minneapolis, MN 1993
   Google Scholar
• Alterman AI, Rutherford MJ, Cacciola JS, McKay JR, Boardman CR. Prediction of seven months methadone maintenance treatment response by four measures of antisociality. Drug Alcohol Depend 1998; 49: 217–223
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Alterman AI, Rutherford MJ, Snidre EC. Treatment response of antisocial substance abusers. J Nerv Ment Dis 1995; 183: 166–171
   PubMed Web of Science ®Google Scholar
• Cecero JJ, Ball SA, Tennen H, Kranzler HR, Rounsaville BJ. Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers. J Nerv Ment Dis 1999; 187: 478–486
   PubMed Web of Science ®Google Scholar
• Crits-Cristoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, Muenz LR, Thase ME, Weiss RD, Gastfriend DR, Woody GE, Barber JP, Butler SF, Daley D, Salloum I, Bishop S, Najavits LM, Lis J, Mercer D, Griffin ML, Moras K, Beck AT. Psychosocial treatments for cocaine dependence: NIDA collaborative cocaine treatment study. Arch Gen Psychiatry 1999; 56: 493–502
   PubMed Web of Science ®Google Scholar
• Powell BJ, Penick EC, Nickel EJ, Liskow BI, Riesenmy KD, Campion SL, Brown EF. Outcomes of comorbid alcoholic men: a one-year follow-up. Alcohol Clin Exp Res 1992; 16: 131–138
   PubMed Web of Science ®Google Scholar
• Verheul R, van den Brink W, Hartgers C, Koeter MWJ. Anti-social alcoholic patients who show as much improvement at fourteen-month follow-up as non-antisocial alcoholic patients. Am J Addict 1999; 8: 24–33
   PubMed Web of Science ®Google Scholar
• Linehan M. Cognitive Behavior Therapy for Borderline Personality Disorder. Guilford Press, New York 1993
   Google Scholar
• Ball SA. Manualized treatment for substance abusers with personality disorders. Addict Behav 1998; 23(6)883–891
   PubMed Web of Science ®Google Scholar